To deal with rising costs, employers are leveraging high performance networks, variable copay plans and exclusive provider ...

BioNTech is acquiring CureVac in a deal that brings messenger RNA manufacturing capability and cancer immunotherapy ...

The letter is an extraordinary rebuke of the Trump administration’s actions against the NIH, which include: terminating hundreds of grants funding scientific and biomedical research; firing more than ...

Arkansas became the first state to pass a law banning pharmacy benefit managers from owning pharmacies, aiming to curb their market power and reduce drug costs. But major PBMs like CVS and Express ...

Behavioral health was once dismissed as secondary: unseen, underfunded, and misunderstood. Not anymore. Its stigma has faded, and the financial cost of neglecting it is too steep to ignore.

If enacted, the GOP’s spending bill could kick more than 10 million Americans off Medicaid. Experts are worried about the ...

Eli Lilly is partnering with Camurus, a company with technology that extends how long an injectable drug lasts in the body, ...

Lucet, a behavioral health company, will acquire Emcara Health, a value-based medical group focused on home care, the companies announced Tuesday. The terms of the deal were not disclosed.

The digitization of data, changes to how patient data is shared, and a wealth of real-world data (RWD) mean hospitals and drug developers can form richer insights on patient populations, improve ...